H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

Clinical trial NCT05552781 · UNKNOWN

Trial details

NCT number: NCT05552781
Sponsor: RedCloud Bio
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2022-08-26
Primary completion: 2025-02-28
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.